论文信息 - Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial. - 字舞流文

Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial.

G. Hortobagyi | S. Chandarlapaty | J. Baselga | M. Gnant | M. Moynahan | Daoqi You | M. Voi | Wei He | David J. Chen | P. Sung | A. Samoila | T. Bhatt | P. Patel